세계의 세포 및 유전자 치료제 제조 서비스 시장 보고서(2025년)

Cell and gene therapy manufacturing services encompass processes dedicated to manufacturing and ensuring the quality of gene and cell therapy products. These services play a pivotal role in developing treatments for degenerative conditions, tissue injuries, and genetic abnormalities. They involve adhering to good manufacturing practices, utilizing ancillary reagents, conducting flow cytometry and immunoassays, and offering gene engineering services.

The primary types of these manufacturing services include gene therapy and cell therapy. Gene therapy involves addressing underlying genetic issues to treat or prevent diseases. These services cater to both commercial manufacturing and clinical applications, targeting diverse medical indications such as central nervous system disorders, ophthalmology diseases, cardiovascular diseases, infectious diseases, orthopedic diseases, and oncology diseases. These specialized services are utilized by academic and research institutes, pharmaceutical and biotechnology companies, and other relevant entities involved in the development and production of cell and gene therapies aimed at addressing various medical conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cell and gene therapy manufacturing services market research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy manufacturing services optical components market statistics, including cell and gene therapy manufacturing services optical components industry global market size, regional shares, competitors with a cell and gene therapy manufacturing services optical components market share, detailed cell and gene therapy manufacturing services optical components market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy manufacturing services optical components industry. This cell and gene therapy manufacturing services optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell & gene therapy manufacturing services market size has grown rapidly in recent years. It will grow from $8.15 billion in 2024 to $9.44 billion in 2025 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to increased R&D investments, regulatory support and frameworks, growing pipeline of cell & gene therapies, industry collaborations and partnerships, increasing global demand for personalized medicine.

The cell & gene therapy manufacturing services market size is expected to see rapid growth in the next few years. It will grow to $17.92 billion in 2029 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to market maturation and commercialization, global expansion of biopharmaceutical manufacturing, increased outsourcing by pharma companies, advancements in automation and robotics, emergence of new therapeutic modalities. Major trends in the forecast period include rising demand for energy efficiency, advanced materials and technologies, compact and modular designs, electrification of transportation, focus on safety and reliability.

The forecast of 17.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. advanced therapies by increasing costs for viral vector production and cell processing services imported from France and Singapore, potentially slowing life-saving treatment availability and raising production costs by 15-20%. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The cell and gene therapy manufacturing services market is anticipated to experience growth due to the increasing prevalence of diseases such as cancer. Cancer's rapid and uncontrolled cell growth has led to a surge in demand for more effective treatments, spurring the development of cell and gene therapies. For example, in January 2023, the American Cancer Society reported a 3.16% increase in cancer cases from 2021 to 2023, highlighting the escalating need for innovative therapies to address this trend.

The market for cell and gene therapy manufacturing services is expected to expand further owing to the rising adoption of personalized medicine. This approach tailors medical treatments to individual patient characteristics, significantly enhancing the efficacy of cell and gene therapies. Notably, in January 2023, the FDA's Center for Drug Evaluation and Research approved 37 new molecular entities in 2022, with 12 of them classified as personalized medicines by the Personalized Medicine Coalition (PMC), signifying the growing prominence of personalized treatments.

Technological advancements are driving trends in the cell and gene therapy manufacturing services market. Companies are embracing innovative technologies to maintain their market positions. For instance, in October 2022, Charles River Laboratories International Inc. introduced the navigation Vector Platform, simplifying GMP Adeno-Associated Virus (AAV) vector manufacturing. This platform drastically reduces the time required for viral vector gene therapy researchers compared to conventional workflows, enhancing efficiency and scalability.

Collaborations and partnerships among key players are reshaping the cell and gene therapy manufacturing services market, fostering innovation and accelerating product development. An instance is the collaboration between Allogene Therapeutics Inc. and Antion Biosciences SA to advance multiplex gene silencing for developing next-generation allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.

In June 2024, Genezen, a gene and cell therapy company based in the United States, acquired UniQure for an undisclosed sum. This acquisition is intended to bolster Genezen's capabilities in gene therapy production, broaden its range of services, and utilize UniQure's expertise to address the increasing demand for innovative gene therapies in the market. UniQure is a biotechnology company located in the Netherlands that focuses on gene therapies for severe diseases.

Major companies operating in the cell & gene therapy manufacturing services market include Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Nikon Corporation, Fujifilm Holdings Corporation, F. Hoffmann-La Roche Ltd, Oxford Biomedica plc, CGT Catapult, bluebird bio Inc., Boehringer Ingelheim International GmbH, Innovative Cellular Therapeutics Co. Ltd., Samsung Biologics Co. Ltd., Novartis International AG, Pfizer Inc., Brammer Bio, AGC Biologics, Cognate BioServices Inc., Paragon Bioservices Inc., Merck KGaA operating as MilliporeSigma, Sarepta Therapeutics Inc., Spark Therapeutics Inc., Orchard Therapeutics plc, Precision BioSciences Inc., PCT a Hitachi Group Company, Aldevron LLC, BioNTech SE

North America was the largest region in the cell and gene therapy manufacturing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cell & gene therapy manufacturing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell and gene therapy manufacturing services market includes revenues earned by cell and gene therapy manufacturing and related services which include analytical and process development, current good manufacturing practice cell therapy manufacturing services of autologous and allogeneic t-cells, natural killer cells, dendritic cells, mesenchymal stem cells, hematopoietic stem cells, and more. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell & Gene Therapy Manufacturing Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell & gene therapy manufacturing services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell & gene therapy manufacturing services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell & gene therapy manufacturing services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Gene Therapy; Cell Therapy
• 2) By Indication: Central Nervous System Disorders; Ophthalmology Diseases; Cardiovascular Diseases; Infectious Diseases; Orthopedic Diseases; Oncology Diseases
• 3) By Application: Commercial Manufacturing; Clinical Manufacturing
• 4) By End-user: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
• Subsegments:
• 1) By Gene Therapy: Viral Vector Manufacturing; Plasmid DNA Production; Gene Editing Services; Formulation And Fill-Finish Services
• 2) By Cell Therapy: Cell Sourcing And Banking; Cell Processing And Expansion; Quality Control And Testing Services; Cryopreservation And Storage Services
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Charles River Laboratories International Inc.; Lonza Group AG; Catalent Inc.; WuXi AppTec; Takara Bio Inc.; Nikon Corporation; Fujifilm Holdings Corporation; F. Hoffmann-La Roche Ltd; Oxford Biomedica plc; CGT Catapult; bluebird bio Inc.; Boehringer Ingelheim International GmbH; Innovative Cellular Therapeutics Co. Ltd.; Samsung Biologics Co. Ltd.; Novartis International AG; Pfizer Inc.; Brammer Bio; AGC Biologics; Cognate BioServices Inc.; Paragon Bioservices Inc.; Merck KGaA operating as MilliporeSigma; Sarepta Therapeutics Inc.; Spark Therapeutics Inc.; Orchard Therapeutics plc; Precision BioSciences Inc.; PCT a Hitachi Group Company; Aldevron LLC; BioNTech SE
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell & Gene Therapy Manufacturing Services Market Characteristics

3. Cell & Gene Therapy Manufacturing Services Market Trends And Strategies

4. Cell & Gene Therapy Manufacturing Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell & Gene Therapy Manufacturing Services Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cell & Gene Therapy Manufacturing Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cell & Gene Therapy Manufacturing Services Market Growth Rate Analysis
• 5.4. Global Cell & Gene Therapy Manufacturing Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cell & Gene Therapy Manufacturing Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cell & Gene Therapy Manufacturing Services Total Addressable Market (TAM)

6. Cell & Gene Therapy Manufacturing Services Market Segmentation

• 6.1. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• Cell Therapy
• 6.2. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Central Nervous System Disorders
• Ophthalmology Diseases
• Cardiovascular Diseases
• Infectious Diseases
• Orthopaedic Diseases
• Oncology Diseases
• 6.3. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Commercial Manufacturing
• Clinical Manufacturing
• 6.4. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic And Research Institutes
• Pharmaceutical And Biotechnology Companies
• Other End-Users
• 6.5. Global Cell & Gene Therapy Manufacturing Services Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Vector Manufacturing
• Plasmid DNA Production
• Gene Editing Services
• Formulation And Fill-Finish Services
• 6.6. Global Cell & Gene Therapy Manufacturing Services Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Sourcing And Banking
• Cell Processing And Expansion
• Quality Control And Testing Services
• Cryopreservation And Storage Services

7. Cell & Gene Therapy Manufacturing Services Market Regional And Country Analysis

• 7.1. Global Cell & Gene Therapy Manufacturing Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cell & Gene Therapy Manufacturing Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market

• 8.1. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell & Gene Therapy Manufacturing Services Market

• 9.1. China Cell & Gene Therapy Manufacturing Services Market Overview
• 9.2. China Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell & Gene Therapy Manufacturing Services Market

• 10.1. India Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell & Gene Therapy Manufacturing Services Market

• 11.1. Japan Cell & Gene Therapy Manufacturing Services Market Overview
• 11.2. Japan Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell & Gene Therapy Manufacturing Services Market

• 12.1. Australia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell & Gene Therapy Manufacturing Services Market

• 13.1. Indonesia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell & Gene Therapy Manufacturing Services Market

• 14.1. South Korea Cell & Gene Therapy Manufacturing Services Market Overview
• 14.2. South Korea Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell & Gene Therapy Manufacturing Services Market

• 15.1. Western Europe Cell & Gene Therapy Manufacturing Services Market Overview
• 15.2. Western Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell & Gene Therapy Manufacturing Services Market

• 16.1. UK Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell & Gene Therapy Manufacturing Services Market

• 17.1. Germany Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell & Gene Therapy Manufacturing Services Market

• 18.1. France Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell & Gene Therapy Manufacturing Services Market

• 19.1. Italy Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell & Gene Therapy Manufacturing Services Market

• 20.1. Spain Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell & Gene Therapy Manufacturing Services Market

• 21.1. Eastern Europe Cell & Gene Therapy Manufacturing Services Market Overview
• 21.2. Eastern Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell & Gene Therapy Manufacturing Services Market

• 22.1. Russia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell & Gene Therapy Manufacturing Services Market

• 23.1. North America Cell & Gene Therapy Manufacturing Services Market Overview
• 23.2. North America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell & Gene Therapy Manufacturing Services Market

• 24.1. USA Cell & Gene Therapy Manufacturing Services Market Overview
• 24.2. USA Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell & Gene Therapy Manufacturing Services Market

• 25.1. Canada Cell & Gene Therapy Manufacturing Services Market Overview
• 25.2. Canada Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell & Gene Therapy Manufacturing Services Market

• 26.1. South America Cell & Gene Therapy Manufacturing Services Market Overview
• 26.2. South America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell & Gene Therapy Manufacturing Services Market

• 27.1. Brazil Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell & Gene Therapy Manufacturing Services Market

• 28.1. Middle East Cell & Gene Therapy Manufacturing Services Market Overview
• 28.2. Middle East Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell & Gene Therapy Manufacturing Services Market

• 29.1. Africa Cell & Gene Therapy Manufacturing Services Market Overview
• 29.2. Africa Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell & Gene Therapy Manufacturing Services Market Competitive Landscape And Company Profiles

• 30.1. Cell & Gene Therapy Manufacturing Services Market Competitive Landscape
• 30.2. Cell & Gene Therapy Manufacturing Services Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cell & Gene Therapy Manufacturing Services Market Other Major And Innovative Companies

• 31.1. WuXi AppTec
• 31.2. Takara Bio Inc.
• 31.3. Nikon Corporation
• 31.4. Fujifilm Holdings Corporation
• 31.5. F. Hoffmann-La Roche Ltd
• 31.6. Oxford Biomedica plc
• 31.7. CGT Catapult
• 31.8. bluebird bio Inc.
• 31.9. Boehringer Ingelheim International GmbH
• 31.10. Innovative Cellular Therapeutics Co. Ltd.
• 31.11. Samsung Biologics Co. Ltd.
• 31.12. Novartis International AG
• 31.13. Pfizer Inc.
• 31.14. Brammer Bio
• 31.15. AGC Biologics

32. Global Cell & Gene Therapy Manufacturing Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell & Gene Therapy Manufacturing Services Market

34. Recent Developments In The Cell & Gene Therapy Manufacturing Services Market

35. Cell & Gene Therapy Manufacturing Services Market High Potential Countries, Segments and Strategies

• 35.1 Cell & Gene Therapy Manufacturing Services Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cell & Gene Therapy Manufacturing Services Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cell & Gene Therapy Manufacturing Services Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer